Acta Med. 2025, 68: 167-169
https://doi.org/10.14712/18059694.2026.8
“A Paralyzing Snack”: An Endocrine Cause of Paralysis
References
1. S, Shizume K, Iino S, et al. The association of periodic paralysis and hyperthyroidism in Japan. J Clin Endocrinol Metab. 1957; 17: 1454–9.
<https://doi.org/10.1210/jcem-17-12-1454>
2. MA, Wayangankar S. Thyrotoxic Periodic Paralysis: A Concise Review of the Literature. Curr Rheumatol Rev. 2016; 12: 190–4.
<https://doi.org/10.2174/1573397112666160404124822>
3. GT, Chow CC, Yeung VT, Chan HH, Li JK, Cockram CS. Thyrotoxic periodic paralysis in a Chinese population. QJM. 1996; 89: 463–8.
<https://doi.org/10.1093/qjmed/89.6.463>
4. SH, Huang CL. Mechanism of thyrotoxic periodic paralysis. J Am Soc Nephrol. 2012; 23: 985–8.
<https://doi.org/10.1681/ASN.2012010046>
<PubMed>
5. MJ, Brown DC, Murphy MB. Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med. 1983; 309: 1414–9.
<https://doi.org/10.1056/NEJM198312083092303>
6. A, Ashwath G, Thimmappa D. Thyrotoxic periodic paralysis: clinical challenges. J Thyroid Res. 2014; 2014: 649502. Retraction in: J Thyroid Res. 2021; 7814159.
<https://doi.org/10.1155/2014/649502>
<PubMed>
7. M, Sarma S. Thyrotoxic Periodic Paralysis. N Engl J Med. 2021; 384(19): e71.
<https://doi.org/10.1056/NEJMicm2030770>
8. KO, Taylor EA, Oh VM, Cheah JS, Aw SE. Hyperinsulinaemia in thyrotoxic hypokalaemic periodic paralysis. Lancet. 1991; 337: 1063–4.
<https://doi.org/10.1016/0140-6736(91)91710-C>
9. DP, da Silva MR, Soong TW, et al. Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell. 2010; 140: 88–98.
<https://doi.org/10.1016/j.cell.2009.12.024>
<PubMed>
10. RM, Carlos-Lima E, Lindsey SC, Kunii IS, Dias-da-Silva MR, Arcisio-Miranda M. Down-regulation of Kir2.6 channel by c-termini mutation D252N and its association with the susceptibility to Thyrotoxic Periodic Paralysis. Neuroscience. 2017; 346: 197–202.
<https://doi.org/10.1016/j.neuroscience.2017.01.019>
11. E, Labrum R, Sweeney MG, et al. Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology. 2009; 72: 1544–7.
<https://doi.org/10.1212/01.wnl.0000342387.65477.46>
<PubMed>
12. G, Ausenda C, Bocchia M, Grassi F, Ciani M, Sassi L. Paralisi della muscolatura bulbare associata a tetraparesi flaccida in corso di tireotossicosi [Bulbar paralysis and flaccid tetraparesis in thyrotoxicosis]. Recenti Prog Med. 2002; 93: 169–71. Italian.
13. YC, Tsai WS, Chau T, Lin SH. Acute hypercapnic respiratory failure due to thyrotoxic periodic paralysis. Am J Med Sci. 2004; 327: 264–7.
<https://doi.org/10.1097/00000441-200405000-00025>
14. SH. Thyrotoxic periodic paralysis: reports of seven patients presenting with weakness in an Asian emergency department. Emerg Med J. 2002; 19: 78–9.
<https://doi.org/10.1136/emj.19.1.78>
<PubMed>
15. M, van Kinschot CMJ, Peeters RP, et al. Thyrotoxic periodic paralysis: an unusual presentation of hyperthyroidism. Neth J Med. 2017; 75: 315–20.
16. AG. Neuromuscular manifestations of Graves’ disease. Mayo Clin Proc. 1972; 47: 919–25.
<https://doi.org/10.1016/S0025-6196(26)05051-2>
17. G, Marks S, Kuzel A, Whitford R. Refractory ventricular fibrillation from thyrotoxic hypokalemic periodic paralysis. Am J Emerg Med. 2025: S0735–6757.
18. C, Lopez L, Boccalandro F, Lavis V. Electrocardiographic changes in thyrotoxic periodic paralysis. Am J Cardiol. 2003; 91: 775–7.
<https://doi.org/10.1016/S0002-9149(02)03431-8>
19. MR, Ivan I, Budiman F, Tamio E. Electrocardiographic Manifestation in Thyrotoxic Periodic Paralysis. Cureus. 2022; 14: e21619.
20. MA, Foote JA, Crapo LM. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch Intern Med. 1999; 159: 601–6.
<https://doi.org/10.1001/archinte.159.6.601>
21. KY, Lee SH, Park HS, Ko SH, Ahn YB, Kim HW. Severe hypokalemia and thyrotoxic paralysis from painless thyroiditis complicated by life-threatening polymorphic ventricular tachycardia and rhabdomyolysis. Intern Med. 2014; 53: 1805–8.
<https://doi.org/10.2169/internalmedicine.53.2419>
22. D, Mugikura S, Goshima T, et al. Rebound Hyperkalemia After Potassium Repletion in Thyrotoxic Periodic Paralysis: A Case Report and Review of Management Implications. Cureus. 2025; 17: e85551.



